Internal Medicine - Issue 4/2015

Original Contributions

295
Do diabetologists choose a therapy rationally?
Basic results of the PROROK project (A prospective observation project to assess the relevance of the difference between fasting glycemia and postprandial glycemia to estimation of success of type 2 diabetes therapy)

Denisa Janíčková Žďárská, Pavlína Piťhová, Tomáš Pavlík, Milan Kvapil

346
Glycation of lens proteins in diabetes and its non-invasive assessment – first experience in the Czech Republic

Jan Škrha Jr, Jan Šoupal, Martin Prázný, Jan Škrha

351
miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?

Pavel Škrha, Aleš Hořínek, Michal Anděl, Jan Škrha


Reviews

291
The position of new antidiabetics in clinical practice: SGLT2 vs DPP4 inhibitors

Jan Šoupal, Martin Prázný

301
Biosimilar insulines – new possibilities of diabetes treatment

Jan Škrha

304
The treatment of diabetes in patients with liver and renal impairment

Martin Haluzík

312
Possibilities of therapy GLP1 RA for diabetics with nephropathy

Alena Adamíková

316
Treatment of GLP1 receptor agonists and body mass control

Petr Žák, Jindřich Olšovský

321
Treatment of an elderly patients with diabetes

Zdeněk Rušavý, Michal Žourek

328
Issues of infection related to diabetic foot syndrome

Milan Flekač

335
Treatment of hypertension in diabetes mellitus

Jiří Widimský Jr

340
Physical activity in patients with microvascular complications of diabetes

Martin Matoulek

355
Progress in the development of insulin pumps and their advanced automatic functions

Martin Prázný

361
The microbial flora in the digestive tract and diabetes

Štěpán Svačina

365
Myokines – muscle tissue hormones

Zuzana Stránská, Štěpán Svačina


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account